Versant Venture Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Versant Venture Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,158,161	Closed	-$321M	–	8
2023 Q4	$321M	Hold	5,158,161	–	–	82.47%	1
2023 Q3	$115M	Buy	+5,158,161	New	+$108M	60.87%	1

Versant Venture Management's RYZB Position: Q1 2024 in Review

Versant Venture Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 5,158,161 shares — an estimated $321M sold.

Versant Venture Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $321M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Versant Venture Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Versant Venture Management sold 5,158,161 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $321M.
Versant Venture Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Versant Venture Management's RayzeBio, Inc. Common Stock position peaked at $321M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Versant Venture Management's 13F filing for Q1 2024, filed 3 May 2024.